44 results
Page 2 of 3
8-K
EX-10.1
10u7bksynl04bk9xgtds
6 Aug 20
Departure of Directors or Certain Officers
9:00am
8-K
EX-10.3
jd8a0tc
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
8-K
EX-10.4
vwty0fm
2 Jun 20
Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics
7:49am
DEFM14A
v8la3fi5c
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
rh2ov8x
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
ooi0ge3v663dpf0ns
6 Mar 20
Preliminary proxy related to merger
5:32pm
424B5
ahhi0ye90 s4
9 Nov 18
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.1
c5zkzuf
7 Nov 18
Zafgen Reports Third Quarter 2018 Operating and Financial Results
4:15pm
424B5
kha0bp
28 Jun 18
Prospectus supplement for primary offering
4:54pm
424B5
ctbkyya5
27 Jun 18
Prospectus supplement for primary offering
4:49pm
8-K
EX-99.1
729xakoadk1z acg737
25 Jun 18
Zafgen Announces Positive Full Results in Phase 2Proof-of-Concept Trial ofZGN-1061 in Patients withDifficult-to-Control Type 2 Diabetes
7:15am
8-K
EX-99.1
as1dibkap
8 May 18
Zafgen Reports First Quarter 2018 Operating and Financial Results
4:09pm
10-K
qq8nw
25 Mar 15
Annual report
12:00am
424B4
vww1p
23 Jan 15
Prospectus supplement with pricing info
12:00am